Inventor · disambiguated record
Rolf Hartmann
Also filed as: HARTMANN ROLF · HARTMANN ROLF W · HARTMANN ROLF WOLFGANG
16 granted patents·8 pending applications·65 citations·filing 1986–2021
90Inventor score
Files withHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH5HARTMANN ROLF4MERCK SHARP & DOHME3HARTMANN ROLF W2UNI DES SAARLANDES2
Top patents by PatentIndex Score
24 records- 0187US8546392B217Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseasesHARTMANN ROLF·Filed 2008·Granted Oct 1, 2013·37 cites·8 claims
- 0278US9271963B2Selective inhibitors of human corticosteroid synthasesHARTMANN ROLF·Filed 2006·Granted Mar 1, 2016·6 cites·25 claims
- 0372US11883387B2PqsR inverse agonistsHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2019·Granted Jan 30, 2024·2 cites·17 claims
- 0471US8541404B2Inhibitors of the human aldosterone synthase CYP11B2HARTMANN ROLF W·Filed 2010·Granted Sep 24, 2013·4 cites·14 claims
- 0570US9394290B2Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseasesHARTMANN ROLF·Filed 2011·Granted Jul 19, 2016·5 cites·7 claims
- 0669US9073929B2Aldosterone synthase inhibitorsHOYT SCOTT B·Filed 2012·Granted Jul 7, 2015·3 cites·20 claims
- 0769US8685960B26-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase CYP11B2HARTMANN ROLF W·Filed 2009·Granted Apr 1, 2014·2 cites·17 claims
- 0868US9745282B2Indoline compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 29, 2017·1 cites·10 claims
- 0958US6559157B2Dihydronaphthalene compoundsDAIICHI SEIYAKU CO·Filed 2001·Granted May 6, 2003·1 cites·7 claims
- 1053US9278093B2Aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 8, 2016·0 cites·9 claims
- 1149US9550750B2Indoline compounds as aldosterone synthase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 24, 2017·0 cites·14 claims
- 1246US2023321123A1INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR LasBHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2021·Application pending·0 cites
- 1343US8361996B2Imidazolyl substituted steroidal and indan-1-one derivativesCOUNCIL SCIENT IND RES·Filed 2006·Granted Jan 29, 2013·0 cites·6 claims
- 1440US2023146507A1N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infectionsHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2021·Application pending·0 cites
- 1539US2011046147A117beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseasesUNI DES SAARLANDES·Filed 2008·Application pending·0 cites
- 1638US4839370ANovel derivatives of 3-aryl-3-cycloalkyl-piperidine-2,6-dioneASTA PHARMA AG·Filed 1987·Granted Jun 13, 1989·4 cites·7 claims
- 1738US2023106506A1NOVEL PqsR INVERSE AGONISTSHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2020·Application pending·0 cites
- 1835US10472326B2PQSR modulatorsHELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH·Filed 2014·Granted Nov 12, 2019·0 cites·9 claims
- 1935US2009105278A1Selective inhibitors of human corticosteroid synthesesUNI DES SAARLANDES·Filed 2005·Application pending·0 cites
- 2029US4745233ADerivatives of 1,1,2,2-tetramethyl-1,2-bis-(2-fluoro-4-hydroxyphenyl)-ethaneASTA WERKE AG CHEM FAB·Filed 1986·Granted May 17, 1988·0 cites·10 claims
- 2129US2014057953A1Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitorsHARTMANN ROLF·Filed 2012·Application pending·0 cites
- 2227US2013089502A1Pet radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronismALLOLIO BRUNO·Filed 2011·Application pending·0 cites
- 2322US2018228858A1A plant extract and compounds for use in wound healingPHYNOVA LTD·Filed 2015·Application pending·0 cites
- 2413US9884839B2Inhibitors of 17Beta-hydroxysteroid dehydrogenases type 1 and type 2ELEXOPHARM GMBH·Filed 2015·Granted Feb 6, 2018·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Rolf Hartmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →